Fundraising Fox

Dr. Michael Wacker

Investor

Managing Partner at BioMedPartners · Produktionstechnologe at Boehringer Ingelheim Venture Fund

Ingelheim am Rhein, Rhineland-Palatinate, Germany

About

An experienced life science entrepreneur who founded and built vaccine and pharmaceutical companies, including GlycoVaxyn (acquired by GSK for $212M in 2015) and served as chairman of Inositec (acquired by Vifor Pharma). He joined BiomedVC in 2019 and advises startups for Innosuisse with expertise in company building and scientific research.

Contact· self-published, not guessed

Experience

  1. Boehringer IngelheimProduktionstechnologecurrent2025 — presentIngelheim am Rhein, Rhineland-Palatinate, Germany

Skills & more

DatenanalyseSix SigmaProjektmanagement
  • Zertifizierter Datenanalyst - deskriptive Datenanalyse in PythonDeggendorf Institute of Technology
  • ProjektmanagerIHK für München und Oberbayern
  • Six Sigma Yellow BeltDeggendorf Institute of Technology

From Dr.'s professional profile.

Colleagues at BioMedPartners

Frequently asked questions

Who is Dr. Michael Wacker?
An experienced life science entrepreneur who founded and built vaccine and pharmaceutical companies, including GlycoVaxyn (acquired by GSK for $212M in 2015) and served as chairman of Inositec (acquired by Vifor Pharma). He joined BiomedVC in 2019 and advises startups for Innosuisse with expertise in company building and scientific research.
Where does Dr. Michael Wacker work?
Dr. Michael Wacker is Managing Partner at BioMedPartners.
Where did Dr. Michael Wacker go to school?
Dr. Michael Wacker studied at Berufsschule Mainz 1; Walter-Mohr-Realschule Traunreut (Mittlere Reife).